Melanotan-associated transverse melanonychia

Transverse melanonychia has multiple causes, but is principally observed as adverse effect to drug intake, such as minocyclin, zidovudine and chemotherapies, like pemetrexed,VAD (vincristine, adriamycin and dexamathasone) and hydroxyurea. Other causes include radiation therapy and electron beam ther...

Full description

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 27; no. 1; pp. 128 - 129
Main Authors Paurobally, D., El Hayderi, L., Richert, B., Andre, J., Nikkels, A.F.
Format Journal Article Web Resource
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.01.2013
Blackwell Publishing
Subjects
alpha-MSH - adverse effects
alpha-MSH - analogs & derivatives
Dermatologie
Dermatology
Female
Follow-Up Studies
Human health sciences
Humans
Injections, Subcutaneous
Melanocytes - drug effects
Melanocytes - metabolism
melanonychia
melanotan
Middle Aged
Nail Diseases - chemically induced
Nail Diseases - pathology
Risk Assessment
Sciences de la santé humaine
Online AccessGet full text

Cover

More Information
Summary:Transverse melanonychia has multiple causes, but is principally observed as adverse effect to drug intake, such as minocyclin, zidovudine and chemotherapies, like pemetrexed,VAD (vincristine, adriamycin and dexamathasone) and hydroxyurea. Other causes include radiation therapy and electron beam therapy.
Bibliography:ArticleID:JDV4399
istex:8B46FD01B717F44D901884ED8257A56759B94275
ark:/67375/WNG-SDVWSJHF-C
scopus-id:2-s2.0-84872848195
ISSN:0926-9959
1468-3083
1468-3083
DOI:10.1111/j.1468-3083.2011.04399.x